[go: up one dir, main page]

Yokoyama et al., 2005 - Google Patents

Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth

Yokoyama et al., 2005

View PDF @Full View
Document ID
15260121682378698008
Author
Yokoyama Y
Ramakrishnan S
Publication year
Publication venue
Cancer: Interdisciplinary International Journal of the American Cancer Society

External Links

Snippet

BACKGROUND Blood vessels in tumors express higher level of aminopeptidase N (APN) compared with normal tissues. It has been reported that peptides that contain asparagine‐ glycine‐arginine (NGR) sequence home to APN in tumor vasculature. Increased expression …
Continue reading at acsjournals.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Yokoyama et al. Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth
Lakka et al. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth
Han et al. EDB fibronectin specific peptide for prostate cancer targeting
Zhai et al. Annexin A2 promotes glioma cell invasion and tumor progression
Stetler-Stevenson et al. Tumor cell interactions with the extracellular matrix during invasion and metastasis
Graham et al. Hypoxia‐mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
Kim et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2
Kumar et al. Inhibition of angiogenesis and tumor growth by SCH221153, a dual αvβ3 and αvβ5 integrin receptor antagonist
Nangia-Makker et al. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers
Kessler et al. Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature
Romanov et al. RGD‐recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro
Go et al. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors
Lafleur et al. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP‐13
Thorseth et al. Uncovering mediators of collagen degradation in the tumor microenvironment
Liu et al. Expression of protease-activated receptor 1 in oral squamous cell carcinoma
Cao et al. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis
Nip et al. The role of the integrin vitronectin receptor, αvβ3 in melanoma metastasis
Goldfarb Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices
Schönherr et al. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co‐culture with fibroblasts and upon induction of decorin expression
Yokoyama et al. Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination
Li et al. Antisense integrin αV and β3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas
Yokoyama et al. Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth
Sargiannidou et al. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis
Jessani et al. Breast cancer cell lines grown in vivo: what goes in isn’t always the same as what comes out
Yokoyama et al. Improved biological activity of a mutant endostatin containing a single amino-acid substitution